Market ScopeMarket Research Future (MRFR) assessed the global stem cell therapy market is likely to exhibit a healthy CAGR to earn decent revenue by 2023.Drivers and Restrains Impacting Stem Cell Therapy MarketThe surge in awareness about therapeutic applications of stem cells in the management of several disease is expected to drive the expansion of the global stem cell therapy market in the near future.
The prevailing sedentary lifestyle, increase in consumption of alcohol, and rise in number of smokers can contribute the upsurge of the stem cell market in the years to come.
On the contrary, the stem cell therapy market value generation can drop owing to the high expense of surgical procedures, chemotherapy treatments, the increase in risk of body cell rejecting cells derived from embryos.
The segment of embryo or cord blood-derived is expected to earn high revenue owing to the high traction of the product.The end-user-based segments of the stem cell therapy market are biotechnology companies, hospitals, contract research organizations, research institutes, and stem cell banks.
The increase in success rate of cancer treatment with stem cell therapy can favor the expansion of North America cell therapy market rise.In Europe, the stem cell therapy market is studied for the UK, Belgium, Netherlands, and France.
The stem cell therapy market in the region can secure the second largest share of the market during the forecast term.